168 related articles for article (PubMed ID: 16303757)
1. A novel role of sodium butyrate in the regulation of cancer-associated aromatase promoters I.3 and II by disrupting a transcriptional complex in breast adipose fibroblasts.
Deb S; Zhou J; Amin SA; Imir AG; Yilmaz MB; Lin Z; Bulun SE
J Biol Chem; 2006 Feb; 281(5):2585-97. PubMed ID: 16303757
[TBL] [Abstract][Full Text] [Related]
2. BRCA1 negatively regulates the cancer-associated aromatase promoters I.3 and II in breast adipose fibroblasts and malignant epithelial cells.
Lu M; Chen D; Lin Z; Reierstad S; Trauernicht AM; Boyer TG; Bulun SE
J Clin Endocrinol Metab; 2006 Nov; 91(11):4514-9. PubMed ID: 16940443
[TBL] [Abstract][Full Text] [Related]
3. [Molecular mechanism of inhibition of sodium butyrate on activation of tumor associated aromatase promoters].
Zhou JF; Liu WL; Chen G; Lu YP; Ma D
Ai Zheng; 2002 Dec; 21(12):1283-7. PubMed ID: 12520731
[TBL] [Abstract][Full Text] [Related]
4. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.
Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE
Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E(2) induces breast cancer related aromatase promoters via activation of p38 and c-Jun NH(2)-terminal kinase in adipose fibroblasts.
Chen D; Reierstad S; Lin Z; Lu M; Brooks C; Li N; Innes J; Bulun SE
Cancer Res; 2007 Sep; 67(18):8914-22. PubMed ID: 17875734
[TBL] [Abstract][Full Text] [Related]
6. JunD and JunB integrate prostaglandin E2 activation of breast cancer-associated proximal aromatase promoters.
Chen D; Reierstad S; Fang F; Bulun SE
Mol Endocrinol; 2011 May; 25(5):767-75. PubMed ID: 21393445
[TBL] [Abstract][Full Text] [Related]
7. Regulation of aromatase expression in breast cancer tissue.
Bulun SE; Lin Z; Zhao H; Lu M; Amin S; Reierstad S; Chen D
Ann N Y Acad Sci; 2009 Feb; 1155():121-31. PubMed ID: 19250199
[TBL] [Abstract][Full Text] [Related]
8. The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters.
Bulun SE; Sebastian S; Takayama K; Suzuki T; Sasano H; Shozu M
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):219-24. PubMed ID: 14623514
[TBL] [Abstract][Full Text] [Related]
9. Identification of PARP-1, Histone H1 and SIRT-1 as New Regulators of Breast Cancer-Related Aromatase Promoter I.3/II.
Kaiser A; Krüger T; Eiselt G; Bechler J; Kniemeyer O; Huber O; Schmidt M
Cells; 2020 Feb; 9(2):. PubMed ID: 32059481
[TBL] [Abstract][Full Text] [Related]
10. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients.
Agarwal VR; Bulun SE; Leitch M; Rohrich R; Simpson ER
J Clin Endocrinol Metab; 1996 Nov; 81(11):3843-9. PubMed ID: 8923826
[TBL] [Abstract][Full Text] [Related]
11. CCAAT/enhancer binding protein delta up-regulates aromatase promoters I.3/II in breast cancer epithelial cells.
Kijima I; Ye J; Glackin C; Chen S
Cancer Res; 2008 Jun; 68(11):4455-64. PubMed ID: 18519709
[TBL] [Abstract][Full Text] [Related]
12. CCAAT/enhancer binding protein beta regulates aromatase expression via multiple and novel cis-regulatory sequences in uterine leiomyoma.
Ishikawa H; Fenkci V; Marsh EE; Yin P; Chen D; Cheng YH; Reisterd S; Lin Z; Bulun SE
J Clin Endocrinol Metab; 2008 Mar; 93(3):981-91. PubMed ID: 18182446
[TBL] [Abstract][Full Text] [Related]
13. Breast tumor aromatase: functional role and transcriptional regulation.
Chen S; Zhou D; Okubo T; Kao YC; Yang C
Endocr Relat Cancer; 1999 Jun; 6(2):149-56. PubMed ID: 10731103
[TBL] [Abstract][Full Text] [Related]
14. Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase.
Yang S; Fang Z; Suzuki T; Sasano H; Zhou J; Gurates B; Tamura M; Ferrer K; Bulun S
J Clin Endocrinol Metab; 2002 May; 87(5):2336-45. PubMed ID: 11994385
[TBL] [Abstract][Full Text] [Related]
15. Estrogen production and action.
Nelson LR; Bulun SE
J Am Acad Dermatol; 2001 Sep; 45(3 Suppl):S116-24. PubMed ID: 11511861
[TBL] [Abstract][Full Text] [Related]
16. Organization of the human aromatase p450 (CYP19) gene.
Bulun SE; Takayama K; Suzuki T; Sasano H; Yilmaz B; Sebastian S
Semin Reprod Med; 2004 Feb; 22(1):5-9. PubMed ID: 15083376
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth.
Catalano S; Giordano C; Panza S; Chemi F; Bonofiglio D; Lanzino M; Rizza P; Romeo F; Fuqua SA; Maggiolini M; Andò S; Barone I
Breast Cancer Res Treat; 2014 Jul; 146(2):273-85. PubMed ID: 24928526
[TBL] [Abstract][Full Text] [Related]
18. Role of CRE-binding protein (CREB) in aromatase expression in breast adipose.
Sofi M; Young MJ; Papamakarios T; Simpson ER; Clyne CD
Breast Cancer Res Treat; 2003 Jun; 79(3):399-407. PubMed ID: 12846424
[TBL] [Abstract][Full Text] [Related]
19. Aromatase activity induction in human adipose fibroblasts by retinoic acids via retinoic acid receptor α.
Wilde J; Erdmann M; Mertens M; Eiselt G; Schmidt M
J Mol Endocrinol; 2013 Oct; 51(2):247-60. PubMed ID: 24023268
[TBL] [Abstract][Full Text] [Related]
20. Aromatase in aging women.
Bulun SE; Zeitoun K; Sasano H; Simpson ER
Semin Reprod Endocrinol; 1999; 17(4):349-58. PubMed ID: 10851574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]